Acelyrin News

Acelyrin | 8-K/A: Current report (Amendment)

Nov 5 05:14

Acelyrin | 8-K: ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

Aug 14 04:18

Acelyrin | 8-K: Current report

Jun 12 05:09

Acelyrin | 8-K/A: Current report (Amendment)

May 29 05:22

Acelyrin | DEFA14A: Others

May 9 20:17

Acelyrin | 8-K: Current report

May 9 20:17

Acelyrin | DEFA14A: Others

Apr 23 04:18

Acelyrin | DEF 14A: Definitive information statements

Apr 23 04:13

Acelyrin | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29 04:51

Acelyrin | 8-K: Current report

Mar 29 04:17

Acelyrin | 8-K: Current report

Mar 20 19:07

Acelyrin | 8-K: Current report

Mar 11 20:07

Acelyrin | 8-K: Current report

Dec 21, 2023 05:38

Acelyrin | 8-K: Current report

Nov 28, 2023 05:31

Acelyrin | 8-K: ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

Nov 8, 2023 05:23

Acelyrin | 8-K: Current report

Aug 22, 2023 04:03

Acelyrin | 8-K: ACELYRIN, INC. Reports Second Quarter 2023 Financial Results and Recent Highlights

Aug 15, 2023 04:22

Acelyrin | 8-K: Current report

Aug 3, 2023 05:05

Acelyrin | 8-K: ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights

Jun 16, 2023 04:22

Acelyrin | 8-K: Current report

May 10, 2023 04:16